Mediphage Bioceuticals Company
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Industry:
Gene Therapy
Technology:
Rare Genetic Disorders
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Headquarters:
Canada
Founded Date:
2016